Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10.12% saline----1件: 299
20.9% Isotonic Saline (IS)----1件: 299
30.9% Isotonic Saline (IS), 4mL----1件: 299
40.9% normal saline (control)----1件: 299
50.9% w/v sodium chloride solution2件: Chloride ion,
Sodium chloride		1件: D02056 --1件: 299
6033841----1件: 299
71,5 (Butylimino)-1,5-dideoxy-D-glucitol1件: Sorbitol1件: D00096 --1件: 299
81-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299
9100 mg ELX (VX-445) / 50 mg TEZ / 75 mg IVA FDC----1件: 299
10100 mg ELX /50 mg TEZ /75 mg IVA FDC----1件: 299
11100 mg ELX/50 mg TEZ /75 mg IVA FDC----1件: 299
12100 mg ELX/50 mg TEZ/75 mg IVA fixed dose combination----1件: 299
13100 mg TEZ/150 mg IVA FDC----1件: 299
14100 mg VX-445 /50 mg TEZ/75 mg IVA FDC----1件: 299
15100 mg VX-445/50 mg TEZ /75 mg IVA FDC----1件: 299
16100 mg/m2 dose----1件: 299
17100-mg ELX (VX-445) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
18100-mg ELX (VX-455) / 50-mg TEZ / 75-mg IVA FDC----1件: 299
19100-mg ELX / 50-mg TEZ / 75 -mg IVA FDC----1件: 299
20100-mg VX-445 / 50-mg TEZ / 75- mg IVA FDC----1件: 299
21100-mg VX-445 / 50-mg TEZ / 75-mg IVA FDC----1件: 299
22100-mg VX-445 /50-mg TEZ/75-mg----1件: 299
23100-mg VX-445/50-mg TEZ/75-mg IVA FDC----1件: 299
24100g ELX / 50mg TEZ / 75mg IVA----1件: 299
25100mg ELX/50mg TEZ /75mg IVA----1件: 299
26100mg VX-445/50mg TEZ /75mg IVA FDC----1件: 299
27150-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
28150mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
292% Chlorhexidine solution wipes1件: Chlorhexidine1件: D07668 --1件: 299
302,3-dihydroxybutanedioic acid----1件: 299
312-aminoethanethiol1件: Cysteamine1件: D03634 --2件: 19, 299
32200 mg/m2 dose----1件: 299
3325-Hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
342622U90 Duramycin1件: Lancovutide---1件: 299
35291844----2件: 246, 299
364% chlorhexidine gluconate liquid skin cleanser1件: Chlorhexidine1件: D07668 --1件: 299
374-phenylbutyrate1件: Phenylbutyric acid---2件: 251, 299
384.2% NaCl/Inhalation solution----1件: 299
394D-710----1件: 299
405-methyltetrahydrofolate and vitamin B121件: Cyanocobalamin4件: D00166 ,
D03615 ,
D03616 ,
D03617 		--1件: 299
4150 mg ELX/25 mg TEZ/37.5 mg IVA----1件: 299
4250 mg ELX/25 mg TEZ/37.5 mg IVA fixed dose combination----1件: 299
435000 IU of cholecalciferol1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
44552-02----2件: 53, 299
456% Hypertonic Saline (HS), 4mL----1件: 299
467% Hypertonic Saline (HS)----1件: 299
477% NaCl----1件: 299
487% saline----1件: 299
4975-mg IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
5080mg ELX / 40mg TEZ / 60mg IVA----1件: 299
51A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)----1件: 299
52AAC Hexal----1件: 299
53ABBV-119----1件: 299
54ABBV-2222----1件: 299
55ABBV-3067----1件: 299
56ABBV-576----1件: 299
57ABELCET1件: Amphotericin B1件: D00203 --1件: 299
58ACC----1件: 299
59ACC600Tabs----1件: 299
60Acebilustat1件: Acebilustat---1件: 299
61Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299
62Acetylcysteine1件: Acetylcysteine1件: D00221 --21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337
63ACETYLCYSTEINE SODIUM1件: Acetylcysteine1件: D00221 --1件: 299
64ACIDE TRANEXAMIQUE MYLAN 0,5 g/ 5 mL, solution injectable----1件: 299
65Active Treatment Group 7% Hypertonic Saline----1件: 299
66Actrapid 100 IU/ml, Solution for injection in a vial----1件: 299
67Actrapid Penfill 100UI/ml----1件: 299
68Ad26.COV2-S.02----1件: 299
69Ad5-CB-CFTR----1件: 299
70Adempas1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 51, 86, 88, 225, 299
71Adempas 0.125 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 299
72Adempas 0.5 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
73Adempas 1.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
74Adempas 2.0 mg1件: Riociguat1件: D09572 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬		11件: Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 86, 299
75Adeno-associated virus-CFTR vector----1件: 299
76Adrenalina----1件: 299
77Adrulipase----1件: 299
78Advagraf prolonged-release hard capsules2件: Manganese citrate,
Tacrolimus		2件: D00107 ,
D08556 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
79AER002----1件: 299
80Aeroquin----1件: 299
81Aerosolized, human, plasma-derived Alpha-1 Antitrypsin----1件: 299
82Aerosoltherapy----1件: 299
83AeroVanc----1件: 299
84AIR DNase----1件: 299
85AIR DNase™----1件: 299
86Ajulemic acid1件: Ajulemic acid1件: D11312 1件: CNR2 💬1件: Neuroactive ligand-receptor interaction 💬3件: 50, 51, 299
87Alanine1件: Alanine1件: D00012 --4件: 6, 13, 298, 299
88Albuterol1件: Salbutamol1件: D02147 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299
89Alendronate1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬7件: 19, 41, 46, 50, 271, 274, 299
90Alendronate sodium1件: Alendronic acid1件: D07119 1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 19, 299
91Alginate1件: Alginic acid1件: D02324 --2件: 53, 299
92Alginate oligosaccharide1件: Alginic acid1件: D02324 --1件: 299
93Allo-hMSCs----2件: 211, 299
94Alpha-1 HC 100 mg----1件: 299
95Alpha-1 HC 200 mg----1件: 299
96Alpha1-Proteinase Inhibitor1件: Alpha-1-proteinase inhibitor---2件: 231, 299
97Alpha1-Proteinase Inhibitor (Human)1件: Alpha-1-proteinase inhibitor---2件: 231, 299
98ALTU-1351件: ALTU-135---1件: 299
99ALTUS-135----1件: 299
100ALX-009----1件: 299
101AMIKACIN1件: Amikacin1件: D02543 --2件: 60, 299
102Amikacin nebulization1件: Amikacin1件: D02543 --1件: 299
103AMIKACIN SULFATE2件: Amikacin,
Sulfate ion		1件: D02543 --1件: 299
104Amikacina1件: Amikacin1件: D02543 --1件: 299
105Amikacina liposomal (Arikace?)1件: Amikacin1件: D02543 --1件: 299
106Amikacine1件: Amikacin1件: D02543 --1件: 299
107Amikacine nebulization1件: Amikacin1件: D02543 --1件: 299
108Amikin, amiklin, amicacin, BB-K8, Biklin, Fabianol, Kaminax, Mikavir, Novamin, Pierami1件: Amikacin1件: D02543 --1件: 299
109Amikin®, amiklin, amicacin, BB-K8, Biklin®, Fabianol®, Kaminax, Mikavir, Novamin®, Pierami1件: Amikacin1件: D02543 --1件: 299
110AMILASA----1件: 299
111Amiloride1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299
112Amiloride HCl1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
113Amiloride Solution for Inhalation1件: Amiloride1件: D07447 3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 299
114Aminoglycoside----1件: 299
115Amitriptylin1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
116Amitriptylin-CT1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
117Amitriptylin-ct Tabletten1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 299
118Amitriptyline1件: Amitriptyline1件: D07448 2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 78, 97, 226, 299
119Amoxicillin1件: Amoxicillin2件: D00229 ,
D07452 		--7件: 6, 46, 63, 96, 97, 222, 299
120Amoxicillin and Clavulanic acid1件: Clavulanic acid1件: D07711 --1件: 299
121Amphotericin----1件: 299
122Amphotericin B1件: Amphotericin B1件: D00203 --1件: 299
123AMYLASE----1件: 299
124Anakinra1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299
125Andecaliximab----4件: 46, 96, 97, 299
126Anti-pseudomonas IgY gargle----1件: 299
127Anti-reflux pharmacotherapy----1件: 299
128Antibiotic----1件: 299
129Antioxidant Cocktail----1件: 299
130Antistaminici H1 - H2----1件: 299
131AP----4件: 2, 6, 13, 299
132AP-PA02----1件: 299
133API----2件: 231, 299
134AquADEK----1件: 299
135AquADEKs-2----1件: 299
136ARCT-032----1件: 299
137ARD-3150----1件: 299
138Arginine1件: Arginine1件: D02982 --11件: 46, 58, 67, 78, 96, 97, 98, 113, 210, 251, 299
139Aridol1件: Mannitol1件: D00062 --1件: 299
140Aridol or Osmohale1件: Mannitol1件: D00062 --1件: 299
141ARIKACE™----1件: 299
142Arikayce1件: Amikacin1件: D02543 --1件: 299
143Arikayce™1件: Amikacin1件: D02543 --1件: 299
144Arikayce™ 140 mg1件: Amikacin1件: D02543 --1件: 299
145Arikayce™ 560 mg1件: Amikacin1件: D02543 --1件: 299
146Arikayce™ 70 mg1件: Amikacin1件: D02543 --1件: 299
147ARINA-1----2件: 228, 299
148ARO-ENaC----1件: 299
149Asthma patients----1件: 299
150ATALUREN1件: Ataluren1件: D09323 --6件: 19, 113, 140, 246, 299, 329
151Ataluren (PTC124®)1件: Ataluren1件: D09323 --1件: 299
152Atorvastatin1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299
153Atropina1件: Atropine1件: D00113 5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 299
154Augmentin1件: Clavulanic acid1件: D07711 --1件: 299
155Aurexis----1件: 299
156Aurexis® (tefibazumab)1件: Tefibazumab1件: D06054 --1件: 299
157Avian polyclonal IgY antibody against PA----1件: 299
158Avibactam1件: Avibactam---1件: 299
159AZD1236----1件: 299
160AZD5634----1件: 299
161AZD5634 for infusion----1件: 299
162AZD5634 for inhalation----1件: 299
163AZD7986----2件: 44, 299
164AZD9668----1件: 299
165Azithromycin1件: Azithromycin2件: D06390 ,
D07486 		--6件: 13, 84, 85, 96, 228, 299
166Azithromycin 250 mg tablets1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
167Azithromycin 500 mg film-coated tablet1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
168AZITHROMYCIN DIHYDRATE1件: Azithromycin2件: D06390 ,
D07486 		--2件: 228, 299
169AZLI----1件: 299
170AZLI 75 mg three times a day (TID)----1件: 299
171AZLI 75 mg three times daily (TID)----1件: 299
172AZLI 75 mg two times a day (BID)/ three times a day (TID)----1件: 299
173AZLI 75 mg two times a day (BID)/three times a day (TID)----1件: 299
174Aztreonam1件: Aztreonam1件: D00240 --2件: 228, 299
175Aztreonam for Inhalation (AI)1件: Aztreonam1件: D00240 --1件: 299
176Aztreonam for Inhalation Solution1件: Aztreonam1件: D00240 --1件: 299
177Aztreonam for Inhalation Solution (AZLI)1件: Aztreonam1件: D00240 --1件: 299
178AZTREONAM LYSINE2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
179Aztreonam Lysine for Inhalation2件: Aztreonam,
Lysine		2件: D00240 ,
D02304 		--1件: 299
180Aztreonam solución para inhalación1件: Aztreonam1件: D00240 --1件: 299
181Aztreonan lysine1件: Lysine1件: D02304 --1件: 299
182Bactrim1件: Trimethoprim1件: D00145 --1件: 299
183BAY 85-8501----1件: 299
184BAY q 3939----1件: 299
185BAY63-2521----3件: 51, 86, 299
186BAY85-8501----1件: 299
187BAYQ3939----1件: 299
188BCG----1件: 299
189BCG TICE Vaccine----1件: 299
190Benralizumab1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
191Beta-Adrenergic cocktail----1件: 299
192Beta-lactam antibiotic----1件: 299
193Bethkis----1件: 299
194BH4----5件: 51, 86, 124, 240, 299
195BH4 20mg----1件: 299
196BH4 5mg----1件: 299
197BI 1265162----1件: 299
198BI 1265162 10 µg----1件: 299
199BI 1265162 100 µg----1件: 299
200BI 1265162 25 µg----1件: 299
201BI 1265162 50 µg----1件: 299
202BI 443651----1件: 299
203Biaxin ( clarithromycin)1件: Clarithromycin1件: D00276 --1件: 299
204BIIL 283 BS (Amelubent)----1件: 299
205BIIL 284 BS, high dose----1件: 299
206BIIL 284 BS, high dose, adult patients----1件: 299
207BIIL 284 BS, high dose, pediatric patients----1件: 299
208BIIL 284 BS, low dose----1件: 299
209BIIL 284 BS, low dose, adult patients----1件: 299
210BIIL 284 BS, low dose, pediatric patients----1件: 299
211BIIL 284 BS, medium dose, adult patients----1件: 299
212BIIL 284 BS, medium dose, pediatric patients----1件: 299
213Biklin----1件: 299
214Bio-25 probiotic----1件: 299
215Bisphosphonate treatment----2件: 113, 299
216BLF----1件: 299
217Blood or Saliva Sample Collection----1件: 299
218Blood sample----20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
219Blood test----6件: 36, 51, 107, 113, 162, 299
220Boost VHC----1件: 299
221Boots High Strength Garlic Odour Controlled1件: Garlic1件: D12020 --1件: 299
222BRAMICIL - 100 MG/ 2 ML SOLUZIONE INIETTABILE 10 FIALE DA 2 ML----1件: 299
223Bramitob----1件: 299
224BRAMITOB - 300 MG/4 ML SOLUZIONE DA NEBULIZZARE 56 CONTENITORI MONODOSE 4 ML----1件: 299
225Bramitob 300mg/4ml Nebuliser Solution----1件: 299
226BRAMITOB*NEBUL 28F 300MG/4ML----1件: 299
227BRAMITOB*NEBUL 56F 300MG/4ML----1件: 299
228Bramitob® administered by PARI eFlow® rapid electronic nebulizer----1件: 299
229Bramitob® administered by PARI LC® PLUS nebulizer----1件: 299
230Brensocatib1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
231Brensocatib 10 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
232Brensocatib 25 mg1件: Brensocatib1件: D12120 1件: CTSC 💬2件: Apoptosis, Lysosome 💬1件: 299
233Broccoli1件: Broccoli---3件: 36, 97, 299
234Broccoli sprouts1件: Broccoli---1件: 299
235Bronchial mucus collection----1件: 299
236Bronchitol1件: Mannitol1件: D00062 --1件: 299
237Bucelipase alfa1件: Bucelipase alfa---1件: 299
238BUDESONIDE1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
239Budesonide-formoterol single inhaler2件: Budesonide,
Formoterol		2件: D00246 ,
D07990 		2件: ADRB2,
NR3C1 💬		9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
240Burlulipase1件: Burlulipase---1件: 299
241C01CA04 - Dopamina1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
242Calcium1件: Calcium---27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299
243Calcium carbonate2件: Calcium,
Carbonate ion		---8件: 13, 19, 46, 53, 75, 96, 235, 299
244Calfactant1件: Calfactant1件: D03317 --1件: 299
245Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299
246Cavosonstat1件: Cavosonstat1件: D10916 --1件: 299
247Cayston1件: Aztreonam1件: D00240 --1件: 299
248Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler1件: Aztreonam1件: D00240 --1件: 299
249CAYSTON aztreonam 75 mg powder and solvent for nebuliser solution1件: Aztreonam1件: D00240 --1件: 299
250CB-280----1件: 299
251CEFALEXIN1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
252Cefepime1件: Cefepime1件: D02376 --2件: 60, 299
253Cefiderocol1件: Cefiderocol1件: D11302 --1件: 299
254Ceftaroline1件: Ceftaroline fosamil1件: D08884 --1件: 299
255Ceftazidim1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
256Ceftazidim Fresenius Kabi1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
257Ceftazidim Fresenius Kabi 2000 mg poeder voor oplossing voor injectie of infusie1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
258Ceftazidima1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
259CEFTAZIDIMA PENTAIDRATO1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
260CEFTAZIDIME1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
261Ceftazidime and tobramycin2件: Ceftazidime,
Tobramycin		3件: D00063 ,
D00921 ,
D07654 		--1件: 299
262CEFTAZIDIME PENTAHYDRATE1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
263Ceftazidime/avibactam2件: Avibactam,
Ceftazidime		2件: D00921 ,
D07654 		--1件: 299
264Ceftolozane1件: Ceftolozane1件: D10097 --1件: 299
265Ceftolozane/Tazobactam2件: Ceftolozane,
Tazobactam		2件: D00660 ,
D10097 		--1件: 299
266Cefuroxim1件: Cefuroxime1件: D00262 --1件: 299
267Cefuroxime1件: Cefuroxime1件: D00262 --2件: 97, 299
268Cephalexin1件: Cephalexin2件: D00263 ,
D00906 		--1件: 299
269CF patients with a G551D mutation and treated with Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
270CFTR Modulators----1件: 299
271CFTR potentiator----1件: 299
272ChAdOx1 nCoV-191件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
273CHF 6333----1件: 299
274CHF6333 (Part 1 - SAD)----1件: 299
275CHF6333 (Part 2 - MAD)----1件: 299
276Chlorhexidine1件: Chlorhexidine1件: D07668 --2件: 86, 299
277Chlorhexidine Gluconate1件: Chlorhexidine1件: D07668 --1件: 299
278Chlorhexidine gluconate oral rinse1件: Chlorhexidine1件: D07668 --1件: 299
279Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338
280CHOLECALCIFEROL1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299
281Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299
282Cholecalciferol (vitaminD3)1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
283Cholecalciferol Pill1件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
284Choline1件: Choline1件: D07690 --4件: 93, 171, 193, 299
285Choline Chloride2件: Chloride ion,
Choline		1件: D07690 --1件: 299
286Choline supplementation1件: Choline1件: D07690 --1件: 299
287CILASTATIN1件: Cilastatin1件: D07698 1件: DPEP1 💬-2件: 60, 299
288Cipro (Ciprofloxacin, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
289Cipro Inhale1件: Ciprofloxacin1件: D00186 --1件: 299
290Ciprofloxacin1件: Ciprofloxacin1件: D00186 --5件: 2, 60, 96, 97, 299
291Ciprofloxacin (BAYQ3939) dry powder for inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
292Ciprofloxacin (Cipro Inhale, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
293Ciprofloxacin (Cipro, BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
294Ciprofloxacin (ciproxin)1件: Ciprofloxacin1件: D00186 --1件: 299
295Ciprofloxacin dispersion for inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
296Ciprofloxacin DPI1件: Ciprofloxacin1件: D00186 --1件: 299
297Ciprofloxacin DPI (BAYQ3939)1件: Ciprofloxacin1件: D00186 --1件: 299
298Ciprofloxacin for Inhalation1件: Ciprofloxacin1件: D00186 --1件: 299
299Ciprofloxacin hydrochloride1件: Ciprofloxacin1件: D00186 --2件: 96, 299
300CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE1件: Ciprofloxacin1件: D00186 --1件: 299
301Ciprofloxacin Inhale1件: Ciprofloxacin1件: D00186 --1件: 299
302Ciprofloxacina----1件: 299
303CIPROFLOXACINA CLORIDRATO----1件: 299
304Ciproxin----1件: 299
305CIPROXIN - 500 MG COMPRESSE RIVESTITE 14 COMPRESSE----1件: 299
306Ciproxin Suspension----1件: 299
307CIPROXIN*6CPR RIV 500MG----1件: 299
308Clarithromycin1件: Clarithromycin1件: D00276 --8件: 6, 63, 84, 96, 97, 222, 228, 299
309Claritromycin----1件: 299
310Claritromycin 500mg film coated tablets----1件: 299
311Clavulanate1件: Clavulanic acid1件: D07711 --1件: 299
312CLAVULANIC ACID1件: Clavulanic acid1件: D07711 --1件: 299
313Clindamycin1件: Clindamycin1件: D00277 --2件: 46, 299
314CLORURO SODICO 7%----1件: 299
315Cobamamide1件: Cobamamide1件: D00042 --1件: 299
316Colfinair 2 MIU Powder for Nebuliser Solution----1件: 299
317Colimicina----1件: 299
318COLIMICINA - 1000000 U/4 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE1 FLACONCINO POLVERE + 1 FIALA SOLVENTE 4 ML----1件: 299
319Colimycine----1件: 299
320COLIMYCINE inhalation----1件: 299
321COLIMYCINE injectable----1件: 299
322COLISTIMETATO SODICO----1件: 299
323Colistimethat-Natrium----1件: 299
324COLISTIMETHATE1件: Colistimethate---1件: 299
325Colistimethate 75 mg inhaled two times daily1件: Colistimethate---1件: 299
326COLISTIMETHATE SODIUM1件: Colistimethate---1件: 299
327COLISTIMETHATE SODIUM (A COMPONENT)1件: Colistimethate---1件: 299
328Colistimethate sodium (BAN, USAN), Colistimethatum natricum, Colistin sodium methanesulfonate2件: Colistimethate,
Colistin		1件: D07746 --1件: 299
329Colistimethate sodium (CMS)1件: Colistimethate---1件: 299
330Colistimethate sodium (promixin)1件: Colistimethate---1件: 299
331COLISTIN1件: Colistin1件: D07746 --1件: 299
332Colistin CF1件: Colistin1件: D07746 --1件: 299
333Colistin Forest - Trockenstechampullen mit Lösungsmittel1件: Colistin1件: D07746 --1件: 299
334COLISTIN MESILATE SODIUM1件: Colistin1件: D07746 --1件: 299
335Colistineb----1件: 299
336COLISTINEB 2MUI----1件: 299
337Colobreathe1件: Colistimethate---1件: 299
338Colomycin----1件: 299
339Comirnaty1件: Tozinameran1件: D11971 --5件: 13, 46, 51, 53, 299
340Comirnaty concentrate for dispersion for injection1件: Tozinameran1件: D11971 --2件: 53, 299
341Compound 1a----2件: 246, 299
342Continuous infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
343Continuous infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
344Continuous infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
345Continuous infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
346Continuous infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
347Control----4件: 6, 46, 168, 299
348Control Group 0.9% Isotonic Saline----1件: 299
349Control multivitamin----1件: 299
350COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299
351COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299
352COVID-19 vaccine (Ad26.COV2-S [recombinant])----1件: 299
353COVID-19 Vaccine (ChAdOx1-S [recombinant])----3件: 46, 51, 299
354COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19)1件: AstraZeneca COVID-19 Vaccine---3件: 46, 51, 299
355Covid-19 Vaccine Janssen1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
356COVID-19 Vaccine Janssen suspension for injection1件: Janssen COVID-19 Vaccine1件: D12129 --1件: 299
357COVID-19 Vaccine Janssen suspension for injection COVID-19 vaccine (Ad26.COV2-S [recombinant])1件: Janssen COVID-19 Vaccine1件: D12129 --2件: 53, 299
358COVID-19 Vaccine Moderna1件: Moderna COVID-19 Vaccine1件: D12114 --4件: 46, 51, 65, 299
359COVID-19 Vaccine Moderna dispersion for injection1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
360CPX----1件: 299
361CR0021件: CR002---1件: 299
362CR002 Liquid API1件: CR002---1件: 299
363CRC3357, ZK-355322, Leukoton----1件: 299
364CREON----2件: 298, 299
365Creon 10.000, hårde enterokapsler----1件: 299
366Creon 10000----2件: 298, 299
367CREON 10000 Capsules----1件: 299
368Creon 25.000, hårde enterokapsler----1件: 299
369Creon 25000----2件: 298, 299
370Creon 40.000, hårde enterokapsler----1件: 299
371CREON IR----1件: 299
372Creon N----1件: 299
373CREON N 25000----1件: 299
374Creon®----1件: 299
375Creon® (DR/GR)----1件: 299
376Creon® 25,000----1件: 299
377Crestor1件: Rosuvastatin1件: D08492 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 49, 79, 299
378CSL787----1件: 299
379CTX-4430----1件: 299
380Curcuma Longa1件: Turmeric---2件: 96, 299
381Curcuma Longa Extract1件: Turmeric---1件: 299
382Curcuma Longa Extract cpl formaat 00 23,2 x 8,5 mm 723 mg1件: Turmeric---1件: 299
383Curcumin1件: Curcumin---10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299
384CYC202----1件: 299
385CYCLO[L-ALANYL-L-SERYL-L-ISOLEUCYL-L-PROLYL-L-PROLYL-L-GLUTAMINYL-L-LYSYL-L-TYROSYL-D-PROLYL-L-PROLYL-(2S)-2-AMINODECANOYL-L-ALPHA-GLUTAMYL-L-THREONYL]----1件: 299
386CYSTAGON1件: Cysteamine1件: D03634 --3件: 8, 19, 299
387Cystagon (cysteamine bitartrate) immediate-release capsules1件: Cysteamine1件: D03634 --1件: 299
388Cysteamine1件: Cysteamine1件: D03634 --4件: 8, 19, 21, 299
389Cysteamine Bitartrate1件: Cysteamine1件: D03634 --4件: 8, 19, 21, 299
390Cysteamine bitartrate (Cystagon)1件: Cysteamine1件: D03634 --1件: 299
391Cystic Fibrosis Ready to Use Supplemental Food----1件: 299
392Cystic fibrosis transmembrane conductance regulator----1件: 299
393D-a-tocopheryl PEG 1000 succinate----1件: 299
394D-glucitol1件: Sorbitol1件: D00096 --2件: 28, 299
395D-IVA----1件: 299
396D6-25-hydroxyvitamin D31件: Calcifediol1件: D00122 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
397DCI----2件: 6, 299
398DCI 1020----1件: 299
399Decolonization----1件: 299
400Denosumab1件: Denosumab1件: D03684 1件: TNFSF11 💬8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬8件: 46, 50, 70, 93, 95, 96, 274, 299
401Denufosol1件: Denufosol---1件: 299
402Denufosol tetrasodium (INS37217)1件: Denufosol---1件: 299
403Denufosol Tetrasodium (INS37217) Inhalation Solution1件: Denufosol---1件: 299
404Denufosol tetrasodium Inhalation Solution1件: Denufosol---1件: 299
405DEPELESTAT----1件: 299
406Desoxyribonuclease1件: Desoxyribonuclease---1件: 299
407Detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
408Detoxifying agents for antineoplastic treatment----2件: 299, 337
409Deuterated Ivacaftor1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
410DEUTIVACAFTOR1件: Deutivacaftor1件: D11423 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
411Dexamethasone1件: Dexamethasone1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
412Dexamethasone sodium phosphate 250 mg/10 ml solution2件: Dexamethasone,
Phosphate ion		1件: D00292 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
413DHA----8件: 6, 46, 48, 49, 94, 113, 299, 301
414DICLOXACILLIN1件: Dicloxacillin1件: D02348 --1件: 299
415Diet----4件: 86, 97, 240, 299
416Digitoxin1件: Digitoxin1件: D00297 4件: ATP1A1,
ATP1A2,
ATP1A3,
ATP1A4 💬		18件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 299
417Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)1件: Azithromycin2件: D06390 ,
D07486 		--1件: 299
418Docosahexaenoic acid1件: Doconexent---7件: 6, 49, 90, 94, 240, 299, 301
419Docosahexaenoic Acid (DHA)1件: Doconexent---3件: 6, 94, 299
420Docosahexaenoic acid administration: 50 mg/kg/day during 12 months1件: Doconexent---1件: 299
421Docosahexanoic Acid1件: Doconexent---1件: 299
422Docosahexanoic Acid Supplement1件: Doconexent---1件: 299
423Dopamina1件: Dopamine1件: D07870 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 299
424DORIBAX1件: Doripenem1件: D03895 --1件: 299
425Doripenem1件: Doripenem1件: D03895 --1件: 299
426DORIPENEM HYDRATE1件: Doripenem1件: D03895 --1件: 299
427Dornase alfa1件: Dornase alfa1件: D03896 --2件: 53, 299
428Dornase alfa (Pulmozyme)1件: Dornase alfa1件: D03896 --1件: 299
429Dornase alfa [Pulmozyme®]1件: Dornase alfa1件: D03896 --1件: 299
430Dornase alpha1件: Dornase alfa1件: D03896 --1件: 299
431Doxycyclin1件: Doxycycline2件: D00307 ,
D07876 		--2件: 97, 299
432Doxycycline1件: Doxycycline2件: D00307 ,
D07876 		--17件: 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299
433DP Mannitol1件: Mannitol1件: D00062 --1件: 299
434Dry powder tobramycin1件: Tobramycin1件: D00063 --1件: 299
435DTPA1件: Pentetic acid1件: D05422 --2件: 28, 299
436Dulaglutide1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
437Dulaglutide 0.75Mg/0.5Ml Inj Pen1件: Dulaglutide1件: D09889 1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 299
438DURAMYCIN1件: Lancovutide---1件: 299
439Duramycin, 2622U901件: Lancovutide---1件: 299
440DX-890----1件: 299
441Ebselen1件: Ebselen---1件: 299
442ECGC----1件: 299
443EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299
444EGCG + Tocotrienol2件: Epigallocatechin gallate,
Tocotrienol		---1件: 299
445Elasomeran1件: Moderna COVID-19 Vaccine1件: D12114 --1件: 299
446ELEXACAFTOR1件: Elexacaftor1件: D11507 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
447Elexacaftor / Ivacaftor / Tezacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
448Elexacaftor 100 MG / Ivacaftor 75 MG / Tezacaftor 50 MG, 2 tablets each morning + Ivacaftor 150 mg one tablet each evening3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
449Elexacaftor-tezacaftor-ivacaftor exposure3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
450Elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
451ELX----1件: 299
452ELX (VX-445)/TEZ (VX-661)/IVA (VX-770)----1件: 299
453ELX-021件: ELX-02---3件: 19, 218, 299
454ELX/TEZ/IVA----1件: 299
455EMEA/H/C/000125----1件: 299
456End-of-life nursing education consortium-pediatric palliative care as web based-training plus usual care----2件: 113, 299
457Engineerd Protein Inhibitor of human Neutrophil Elastase----1件: 299
458Engineered Protein Inhibitor of human Neutrophil Elastase----1件: 299
459Ensure High Protein----1件: 299
460Ensure plus----1件: 299
461EPI-hNE4 DX-890----1件: 299
462Ergocalciferol1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 46, 84, 96, 97, 299
463Ergocalciferol (vitamin D2)1件: Ergocalciferol1件: D00187 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
464Esomeprazole1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299
465Essential amino acid intake + Leucine vs total AA supplement1件: Leucine1件: D00030 --1件: 299
466Estradiol1件: Estradiol1件: D00105 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬7件: 13, 46, 49, 65, 76, 226, 299
467Estradiol 2 mg1件: Estradiol1件: D00105 2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
468ETD001 multiple once daily doses----1件: 299
469ETD001 multiple twice daily doses----1件: 299
470ETD001 single dose----1件: 299
471Ethambutol1件: Ethambutol1件: D07925 --2件: 84, 299
472Ethinyl estradiol2件: Estradiol,
Ethinylestradiol		2件: D00105 ,
D00554 		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬3件: 46, 49, 299
473EU Orphan Designation Number EU/3/02/120----1件: 299
474EUR-1008----1件: 299
475EUR-1008 (APT-1008)----1件: 299
476EUR-1008 25,000 Units----1件: 299
477Ex-vivo approach concerning 25 patients----2件: 102, 299
478Exercise----1件: 299
479EZ-2053----2件: 85, 299
480EZ-2053 5mg/kg----2件: 85, 299
481F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid)----1件: 299
482Fasenra1件: Benralizumab1件: D09874 1件: IL5RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬5件: 44, 45, 98, 162, 299
483FDL1691件: FDL169---1件: 299
484FDL176----1件: 299
485FDL176 & FDL169 coadministration1件: FDL169---1件: 299
486Fenretinide1件: Fenretinide1件: D04162 2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬1件: 299
487Ferinject----2件: 86, 299
488FERRIC CARBOXYMALTOSE1件: Ferric carboxymaltose1件: D08920 --4件: 86, 96, 97, 299
489Ferrous sulfate 325mg1件: Sulfate ion---1件: 299
490Finely ground flaxseed powder1件: Flax seed---1件: 299
491Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299
492Flaxseed1件: Flax seed---2件: 97, 299
493FLUCLOXACILLIN1件: Flucloxacillin1件: D04196 --1件: 299
494Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution1件: Flucloxacillin1件: D04196 --1件: 299
495FLUCLOXACILLIN SODIUM1件: Flucloxacillin1件: D04196 --1件: 299
496Flucloxicillin----1件: 299
497FluMist1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
498Flumist®1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen---1件: 299
499Fluticasone1件: Fluticasone1件: D07981 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 98, 228, 299
500FORLAX 4 g, poudre pour solution buvable en sachet----1件: 299
501Formoterol1件: Formoterol1件: D07990 1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 85, 228, 299
502Fortum----1件: 299
503FTI, AZLI----1件: 299
504Fucidin1件: Fusidic acid1件: D04281 --1件: 299
505Fucidin Tablets1件: Fusidic acid1件: D04281 --1件: 299
506Fusidate1件: Fusidic acid1件: D04281 --1件: 299
507FUSIDIC ACID1件: Fusidic acid1件: D04281 --1件: 299
508Fusidin----1件: 299
509G1117337----2件: 67, 299
510G914167----1件: 299
511G957389----1件: 299
512GALICAFTOR1件: Galicaftor1件: D11724 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
513Gallium nitrate2件: Gallium nitrate,
Nitrate		2件: D00940 ,
D02313 		--1件: 299
514Garlic1件: Garlic1件: D12020 --1件: 299
515Genetic testing----3件: 6, 90, 299
516GENISTEIN1件: Genistein1件: D11680 --2件: 19, 299
517Genistein (Unconjugated Isoflavones 100)1件: Genistein1件: D11680 --1件: 299
518Genisteine Plus 150 mg cpl formaat 1 18,7 x 6,4 mm 438 mg----1件: 299
519Gentamicin1件: Gentamicin1件: D08013 --3件: 36, 113, 299
520Gernebcin----1件: 299
521Gernebcin 80 mg----1件: 299
522Ghrelin1件: Lenomorelin---6件: 6, 78, 193, 201, 202, 299
523GIP----1件: 299
524Giving DHA-rich supplement----1件: 299
525Glargine----1件: 299
526Glargine insulin----1件: 299
527GLP-1----1件: 299
528GLPG1837----1件: 299
529GLPG1837 dose 1----1件: 299
530GLPG1837 dose 2----1件: 299
531GLPG1837 dose 3----1件: 299
532GLPG2222----1件: 299
533GLPG2222 100 mg----1件: 299
534GLPG2222 150 mg q.d.----1件: 299
535GLPG2222 200 mg----1件: 299
536GLPG2222 300 mg q.d.----1件: 299
537GLPG2222 400 mg----1件: 299
538GLPG2222 50 mg----1件: 299
539GLPG2451 dose regimen A----1件: 299
540GLPG2451 dose regimen B----1件: 299
541GLPG2737----2件: 67, 299
542GLPG2737 single dose----1件: 299
543GLPG3067----1件: 299
544GLPG3067 single dose----1件: 299
545Glucose1件: Dextrose, unspecified form---12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299
546Glutamine1件: L-Glutamine1件: D00015 --8件: 87, 89, 96, 97, 113, 222, 245, 299
547Glutathione1件: Glutathione2件: D00014 ,
D00031 		--2件: 6, 299
548GLUTATHIONE SODIUM1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
549GLYCINE1件: Glycine1件: D00011 --5件: 35, 60, 86, 226, 299
550Glycine Buffer1件: Glycine1件: D00011 --1件: 299
551GlycosBio Nutritional Supplement----1件: 299
552GLYPRESSINE 1 mg/5 mL, poudre et solvant pour solution injectable (I.V.)----1件: 299
553Growth hormone1件: Somatotropin---14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299
554GS-5737----1件: 299
555GS-57451件: GS-5745---4件: 46, 96, 97, 299
556GS-9411----1件: 299
557GSH----2件: 6, 299
558GSH (Glutathione)1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
559H02 - Corticosteroidi Sistemici----1件: 299
560H5.001CBCFTR----1件: 299
561Helium1件: Helium1件: D04420 --3件: 228, 299, 330
562Helium-32件: Helium,
Helium He-3		1件: D04420 --2件: 228, 299
563Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬11件: 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317
564Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299
565Heparin Sodium1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬2件: 280, 299
566Heracillin----1件: 299
567High dose of budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
568High-Dose Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
569HMSCs----1件: 299
570HP 129Xe----1件: 299
571HP 3He----1件: 299
572HSK31858----1件: 299
573Human recombinant growth hormone1件: Somatotropin---2件: 13, 299
574Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
575Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
576Hyperglycemic clamp----1件: 299
577Hyperglycemic Clamp with concurrent GIP infusion----1件: 299
578Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299
579Hyperpolarized Helium-32件: Helium,
Helium He-3		1件: D04420 --1件: 299
580Hyperpolarized Helium-3 MRI of the chest2件: Helium,
Helium He-3		1件: D04420 --1件: 299
581Hyperpolarized Xe129----4件: 51, 85, 86, 299
582Hyperpolarized Xenon1件: Xenon2件: D01901 ,
D06339 		--1件: 299
583Hyperpolarized Xenon 1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
584Hyperpolarized Xenon gas1件: Xenon2件: D01901 ,
D06339 		--1件: 299
585Hyperpolarized xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
586Hypertonic bicarbonate----1件: 299
587HYPERTONIC SALINE----1件: 299
588Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299
589Hypertonic saline (7%)----1件: 299
590Hypertonic saline 6% -----1件: 299
591Hypertonic Saline 7%1件: Sodium chloride1件: D02056 --1件: 299
592Hypertonic saline solution1件: Sodium chloride1件: D02056 --1件: 299
593Ibuprofen1件: Ibuprofen1件: D00126 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299
594Icenticaftor----1件: 299
595ICS+LABA----1件: 299
596IDPM----1件: 299
597IDPM: Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
598IGE025----1件: 299
599IgY----1件: 299
600IMIPENEM1件: Imipenem2件: D00206 ,
D04515 		--2件: 60, 299
601Imipenem/Cilastatin/Relebactam3件: Cilastatin,
Imipenem,
Relebactam		4件: D00206 ,
D04515 ,
D07698 ,
D10726 		1件: DPEP1 💬-1件: 299
602Impact----5件: 46, 50, 53, 85, 299
603Impact-Nutridrink----1件: 299
604In-vitro approach concerning 25 patients----2件: 102, 299
605Increlex1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬4件: 65, 78, 96, 299
606INCRELEX*SC 1FL 4ML 10MG/ML1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 299
607Indium1件: Indium---3件: 28, 84, 299
608Indium-DTPA2件: Indium,
Pentetic acid		1件: D05422 --1件: 299
609INDUSIL*OS GTT FL 30MG+FL 15ML----1件: 299
610Influenza vaccination----1件: 299
611Inhaled 7% hypertonic saline (HS)----1件: 299
612Inhaled AR-501----1件: 299
613Inhaled Dry Powder Mannitol1件: Mannitol1件: D00062 --1件: 299
614Inhaled hypertonic saline (7%)----1件: 299
615Inhaled Mannitol1件: Mannitol1件: D00062 --1件: 299
616Inhaled Reduced Glutathione1件: Glutathione2件: D00014 ,
D00031 		--1件: 299
617Inhaled SNSP113----1件: 299
618Inhaled Sodium Pyruvate----1件: 299
619Inhaled tobramycin1件: Tobramycin1件: D00063 --1件: 299
620Inhaled Vancomycin1件: Vancomycin1件: D00212 --1件: 299
621Initiation of CFTR Modulator----1件: 299
622INOmax1件: Nitric Oxide1件: D00074 --3件: 85, 294, 299
623INOmax 400ppm mol/mol inhalation gas1件: Nitric Oxide1件: D00074 --2件: 85, 299
624INS1007----2件: 44, 299
625INS1007 10 mg oral tablet----1件: 299
626INS1007 25 mg oral tablet----1件: 299
627Insulin----6件: 6, 13, 46, 75, 78, 299
628Insulin Asparte----1件: 299
629Insulin detemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
630Insulin detemir [rDNA origin] injection1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
631Insulin glargine1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
632Insuline humaine recombinante----1件: 299
633Interferon Gamma1件: Interferon Gamma---8件: 18, 65, 85, 107, 228, 299, 301, 326
634INTERFERON GAMMA-1B2件: Interferon Gamma,
Interferon gamma-1b		1件: D00747 2件: IFNGR1,
IFNGR2 💬		18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬7件: 18, 65, 85, 228, 299, 301, 326
635Intermittent, short infusion Cefepime1件: Cefepime1件: D02376 --1件: 299
636Intermittent, short infusion Ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
637Intermittent, short infusion Meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
638Intermittent, short infusion Piperacillin tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
639Intermittent, short infusion Ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
640Inulin1件: Inulin1件: D00171 --4件: 6, 96, 156, 299
641IONIS-ENaCRx----1件: 299
642ISOTONIC SALINE----1件: 299
643Isotonic saline 0.9%1件: Sodium chloride1件: D02056 --1件: 299
644Itraconazole1件: Itraconazole1件: D00350 --6件: 3, 46, 65, 96, 227, 299
645Itraconazole/voriconazole2件: Itraconazole,
Voriconazole		2件: D00350 ,
D00578 		--1件: 299
646IV amikacin1件: Amikacin1件: D02543 --1件: 299
647IV ceftazidime1件: Ceftazidime2件: D00921 ,
D07654 		--1件: 299
648IV meropenem1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
649IV piperacillin-tazobactam2件: Piperacillin,
Tazobactam		3件: D00660 ,
D02251 ,
D08380 		--1件: 299
650IV ticarcillin-clavulanate2件: Clavulanic acid,
Ticarcillin		2件: D07711 ,
D08593 		--1件: 299
651IV tobramycin1件: Tobramycin1件: D00063 --1件: 299
652IV vancomycin hydrochloride1件: Vancomycin1件: D00212 --1件: 299
653IVA----1件: 299
654IVACAFTOR1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
655Ivacaftor (proposed INN)1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
656Ivacaftor 125mg tablet1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
657Ivacaftor 150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
658Ivacaftor 150 mg or 250 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
659Ivacaftor 25 mg/75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
660IVACAFTOR 59,5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
661IVACAFTOR 59.5mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
662Ivacaftor 75 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
663Ivacaftor 75 mg/150 mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
664IVACAFTOR 75mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
665Ivacaftor Exposed1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
666Ivacaftor or elexacaftor/tezacaftor/ivacaftor3件: Elexacaftor,
Ivacaftor,
Tezacaftor		3件: D09916 ,
D11041 ,
D11507 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
667Ivacaftor+lumacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
668Ivacaftor/Ataluren2件: Ataluren,
Ivacaftor		2件: D09323 ,
D09916 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
669Ivacaftor/Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
670Ivacaftor/Trikafta1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
671J01GB01----1件: 299
672JBT-101----4件: 49, 50, 51, 299
673JBT-101 (lenabasum)----1件: 299
674JBT101----1件: 299
675Kaftrio1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
676Kalydeco1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
677Kalydeco 150 mg film-c1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
678Kalydeco 150 mg film-coated tablets1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
679Kalydeco 150mg1件: Ivacaftor1件: D09916 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
680KB0011件: KB001---1件: 299
681KB001-A1件: KB001---1件: 299
682KB407 (Nebulization)----1件: 299
683Ketone Monoester----1件: 299
684Kineret1件: Anakinra1件: D02934 2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬9件: 28, 41, 46, 49, 65, 106, 107, 266, 299
685Klacid----1件: 299
686Kreon 25 000----1件: 299
687Kreon 25,000 Units----1件: 299
688Kreon 25000----2件: 298, 299
689KREON de Liberación Inmediata----1件: 299
690KREON N 25000----1件: 299
691Kreon® 25,000----1件: 299
692L-alanine1件: Alanine1件: D00012 --1件: 299
693L-arginine1件: Arginine1件: D02982 --8件: 46, 67, 78, 96, 97, 98, 113, 299
694L-Glutamine1件: L-Glutamine1件: D00015 --2件: 113, 299
695L-Lysine N acetylcysteinate1件: Lysine1件: D02304 --1件: 299
696L-Lysine N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
697L-Lysine- N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
698L-Lysine-N-acetyl-L-cysteinate1件: Lysine1件: D02304 --1件: 299
699L-Lysine-N-acetylcysteinate1件: Lysine1件: D02304 --1件: 299
700LABA/LAMA----1件: 299
701Lactic acid1件: Lactic acid1件: D00111 --1件: 299
702Lactic acid producing organisms1件: Lactic acid1件: D00111 --1件: 299
703Lactizole nebulization----1件: 299
704Lactobacillus1件: Lactobacillus delbrueckii bulgaricus---5件: 6, 46, 51, 97, 299
705LACTOBACILLUS REUTERI1件: Lactobacillus reuteri---2件: 97, 299
706Lactobacillus rhamnosus1件: Lactobacillus delbrueckii bulgaricus---1件: 299
707Lactobacillus rhamnosus GG1件: Lactobacillus delbrueckii bulgaricus---1件: 299
708Lansoprazole1件: Lansoprazole1件: D00355 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬7件: 63, 71, 85, 98, 166, 222, 299
709Lantus 100 units/ml solution for injection in a cartridge----1件: 299
710LANTUS*SC 5CAR3ML100UI/ML1件: Insulin glargine1件: D03250 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
711Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----1件: 299
712LAU-7b----1件: 299
713Lefamulin1件: Lefamulin1件: D11631 --1件: 299
714Lenabasum----3件: 50, 51, 299
715Lenabasum 20 mg----2件: 51, 299
716Lenabasum 5 mg----2件: 51, 299
717Leucine1件: Leucine1件: D00030 --6件: 6, 19, 65, 283, 284, 299
718Levemir1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
719Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
720Levemir FlexPen1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
721Levemir Penfill1件: Insulin detemir1件: D04539 1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 299
722Levofloxacin1件: Levofloxacin2件: D00588 ,
D08120 		--4件: 46, 53, 84, 299
723LEVOFLOXACIN HEMIHYDRATE1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
724Levofloxacin Kabi1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
725Linez----1件: 299
726LINEZOLID1件: Linezolid1件: D00947 --1件: 299
727Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299
728Linoleic acid supplementation1件: Linoleic acid---1件: 299
729LIPASA----1件: 299
730LIPASE----2件: 298, 299
731Lipase CLEC----1件: 299
732LIPASE LIP2----1件: 299
733Lipase Lip2 from Yarrowia lipolytica----1件: 299
734Lipitor1件: Atorvastatin1件: D07474 1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 51, 96, 299
735Liposomal Amikacin1件: Amikacin1件: D02543 --1件: 299
736Liposomal Amikacin (Arikace TM)1件: Amikacin1件: D02543 --1件: 299
737Liposomal Amikacin (Arikace™)1件: Amikacin1件: D02543 --1件: 299
738Liposomal amikacin for inhalation1件: Amikacin1件: D02543 --1件: 299
739Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.1件: Amikacin1件: D02543 --1件: 299
740Liposomal amphotericin B (Ambisome®)1件: Amphotericin B1件: D00203 --1件: 299
741Liprotamasa----1件: 299
742Liprotamase----2件: 298, 299
743Liprotamase Powder for Oral Solution----1件: 299
744Loestrin (norethindrone acetate and ethinyl estradiol)4件: Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone		3件: D00105 ,
D00182 ,
D00554 		3件: ESR1,
ESR2,
PGR 💬		12件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 299
745Lonodelestat----1件: 299
746Losartan1件: Losartan1件: D08146 1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
747LU 70274----1件: 299
748LUBIPROSTONE1件: Lubiprostone1件: D04790 1件: CLCN2 💬1件: Mineral absorption 💬4件: 6, 13, 290, 299
749Lucinactant1件: Lucinactant1件: D04792 --1件: 299
750Lucinactant first1件: Lucinactant1件: D04792 --1件: 299
751LUM----1件: 299
752LUM/IVA----1件: 299
753LUM/IVA fixed-dose combination----1件: 299
754LUMACAFTOR1件: Lumacaftor1件: D10134 1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
755Lumacaftor / ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
756Lumacaftor plus Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
757Lumacaftor Plus Ivacaftor Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
758Lumacaftor, Ivacaftor Drug Combination2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
759Lumacaftor-ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
760Lumacaftor-Ivacaftor treatment2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
761Lumacaftor/Ivacaftor2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
762Lumacaftor/ivacaftor 100mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
763Lumacaftor/ivacaftor 200mg/125mg2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
764Lumacaftor/ivacaftor 200mg/125mg tablets2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
765Lumacaftor/ivacaftor 200mg/83mg tablet2件: Ivacaftor,
Lumacaftor		2件: D09916 ,
D10134 		1件: CFTR 💬8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299
766Lym-X-Sorb powder----1件: 299
767Lysine1件: Lysine1件: D02304 --4件: 13, 97, 228, 299
768Lysomucil 10 %----1件: 299
769Macrogol1件: Polyethylene glycol1件: D03370 --1件: 299
770Macrogol 40001件: Polyethylene glycol1件: D03370 --1件: 299
771MAG-DHA----1件: 299
772Mannite1件: Mannitol1件: D00062 --1件: 299
773Mannitol1件: Mannitol1件: D00062 --7件: 6, 13, 28, 60, 96, 113, 299
774Mannitol + pulmozyme2件: Dornase alfa,
Mannitol		2件: D00062 ,
D03896 		--1件: 299
775Mannitol Inhalant Product1件: Mannitol1件: D00062 --1件: 299
776Mannitol inhalation powder1件: Mannitol1件: D00062 --1件: 299
777Matched isoglycemic clamp----1件: 299
778Mecasermin1件: Mecasermin1件: D03297 2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299
779MEDI-563----5件: 44, 45, 98, 162, 299
780Medical Grade Oxygen1件: Oxygen1件: D00003 --1件: 299
781Melphalan1件: Melphalan1件: D00369 --15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299
782Menadiol Diphosphate1件: Menadiol diphosphate1件: D08176 --1件: 299
783Menadiol sodium diphosphate1件: Kappadione1件: D04908 --1件: 299
784MEROPENEM1件: Meropenem2件: D02222 ,
D08185 		--2件: 60, 299
785Meropenem Fresenius Kabi1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
786Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
787Meropenem Infusion1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
788MEROPENEM TRIHYDRATE1件: Meropenem2件: D02222 ,
D08185 		--1件: 299
789Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299
790Metformin1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301
791METFORMIN HYDROCHLORIDE1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301
792Metformine1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬3件: 46, 81, 299
793Metformine HCL 500 PCH1件: Metformin1件: D04966 2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 299
794Midazolam1件: Midazolam1件: D00550 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
795MIGLUSTAT1件: Miglustat1件: D05032 1件: UGCG 💬2件: Metabolic pathways, Sphingolipid metabolism 💬3件: 19, 256, 299
796Minocycline1件: Minocycline1件: D05045 --13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299
797Minocycline Hydrochloride1件: Minocycline1件: D05045 --4件: 13, 201, 206, 299
798MMF----16件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299
799Modified lipid formulation----1件: 299
800Modified Oral Glucose Tolerance Test (50g 4-hours)1件: Dextrose, unspecified form---1件: 299
801Molgramostim1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬3件: 97, 229, 299
802Molgramostim nebulizer solution1件: Molgramostim1件: D05066 1件: CSF2RA 💬4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 299
803MOLI 1901----1件: 299
804Moli 1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
805Moli1901----1件: 299
806Moli1901 (2622U90, duramycin)1件: Lancovutide---1件: 299
807Moxifloxacin1件: Moxifloxacin1件: D08237 --9件: 2, 6, 46, 49, 85, 86, 113, 240, 299
808Moxifloxacin Hydrochloride1件: Moxifloxacin1件: D08237 --2件: 113, 299
809MP-376----1件: 299
810MP-376 (Levofloxacin Solution for Inhalation)1件: Levofloxacin2件: D00588 ,
D08120 		--1件: 299
811MRI with PFP----1件: 299
812MRT5005----1件: 299
813MS1819----2件: 298, 299
814MS1819-SD1件: MS-1819---2件: 298, 299
815MSI-1995----1件: 299
816MTT----1件: 299
817Mucoid exopolysaccharide P. aeruginosa immune globulin IV----1件: 299
818Mucolysin----1件: 299
819Mucomyst1件: Acetylcysteine1件: D00221 --1件: 299
820Multienzymes (lipase, protease etc.)----2件: 298, 299
821Mupirocin1件: Mupirocin1件: D01076 --2件: 227, 299
822Mupirocin Intranasal Creme1件: Mupirocin1件: D01076 --1件: 299
823N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide----1件: 299
824N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide----1件: 299
825N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide----1件: 299
826N-acetylcystein----1件: 299
827N-Acetylcysteine1件: Acetylcysteine1件: D00221 --13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337
828N-acetylcysteine (NAC)1件: Acetylcysteine1件: D00221 --2件: 51, 299
829N6022----1件: 299
830N91115----1件: 299
831NAC----4件: 51, 85, 90, 299
832Nacystelyn----1件: 299
833Nacystelyn®----1件: 299
834NAL----2件: 6, 299
835Nasal Aztreonam1件: Aztreonam1件: D00240 --1件: 299
836Navocaftor----1件: 299
837NEB/01-07----1件: 299
838Nebcin----1件: 299
839Nebcin (tobramycin)1件: Tobramycin1件: D00063 --1件: 299
840Nebcinal----1件: 299
841Nebcinal Tobi----1件: 299
842NEBCINE----1件: 299
843Nebulization of Amikacin during NIV (RR: 15 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
844Nebulization of Amikacin during NIV (RR: 25 cycles/minute)1件: Amikacin1件: D02543 --1件: 299
845Nebulization tobramycin1件: Tobramycin1件: D00063 --1件: 299
846Nexium1件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
847Nexium 201件: Esomeprazole1件: D07917 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 299
848Nitrate1件: Nitrate1件: D02313 --4件: 58, 67, 113, 299
849NITRIC OXIDE1件: Nitric Oxide1件: D00074 --7件: 85, 86, 88, 210, 251, 294, 299
850Nitric Oxide 160 ppm1件: Nitric Oxide1件: D00074 --1件: 299
851Nitric Oxide for inhalation1件: Nitric Oxide1件: D00074 --2件: 86, 299
852Nitrogen1件: Nitrogen1件: D00083 --5件: 5, 6, 17, 211, 299
853NO----9件: 6, 46, 58, 62, 86, 97, 222, 299, 321
854None----20件: 6, 46, 51, 65, 66, 78, 84, 85, 96, 97, 140, 160, 161, 171, 222, 231, 246, 271, 299, 337
855None assigned1件: Interleukin-1 alpha, human recombinant---2件: 231, 299
856Norethindrone1件: Norethisterone1件: D00182 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299
857Norgestimate1件: Norgestimate1件: D05209 1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 299
858Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49,